Motor cortex stimulation activates the incertothalamic pathway in an animal model of spinal cord injury by 李⑤챸�썕
Motor Cortex Stimulation Activates the Incertothalamic Pathway
in an Animal Model of Spinal Cord Injury
Myeounghoon Cha*, Yadong Ji*, and Radi Masri*,†
*Department of Endodontics, Prosthodontics and Operative Dentistry, University of Maryland
Baltimore, School of Dentistry, Baltimore, Maryland †Department of Anatomy and Neurobiology,
University of Maryland Medical School, Baltimore, Maryland
Abstract
We have shown previously that electrical stimulation of the motor cortex reduces spontaneous
painlike behaviors in animals with spinal cord injury (SCI). Because SCI pain behaviors are
associated with abnormal inhibition in the inhibitory nucleus zona incerta (ZI) and because
inactivation of the ZI blocks motor cortex stimulation (MCS) effects, we hypothesized that the
antinociceptive effects of MCS are due to enhanced inhibitory inputs from ZI to the posterior
thalamus (Po)—an area heavily implicated in nociceptive processing. To test this hypothesis, we
used a rodent model of SCI pain and performed in vivo extracellular electrophysiological
recordings in single well-isolated neurons in anesthetized rats. We recorded spontaneous activity
in ZI and Po from 48 rats before, during, and after MCS (50 μA, 50 Hz; 300-ms pulses). We
found that MCS enhanced spontaneous activity in 35% of ZI neurons and suppressed spontaneous
activity in 58% of Po neurons. The majority of MCS-enhanced ZI neurons (81%) were located in
the ventrorateral subdivision of ZI—the area containing Po-projecting ZI neurons. In addition, we
found that inactivation of ZI using muscimol (GABAA receptor agonist) blocked the effects of
MCS in 73% of Po neurons. Although we cannot eliminate the possibility that muscimol spread to
areas adjacent to ZI, these findings support our hypothesis and suggest that MCS produces
antinociception by activating the incertothalamic pathway.
Perspective—This article describes a novel brain circuit that can be manipulated, in rats, to
produce antinociception. These results have the potential to significantly impact the standard of
care currently in place for the treatment of patients with intractable pain.
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A common consequence of spinal cord injury (SCI) is the development of severe,
debilitating neuropathic pain. The pain is spontaneous and persistent in the absence of an
insult, but it can also present as hypersensitivity to painful stimuli (hyperalgesia) and
hypersensitivity to normally innocuous stimuli (allodynia).12,13 Unfortunately, current
treatments cannot produce complete relief of the pain and are not effective in all patients.2,14
One potential treatment, motor cortex stimulation (MCS), was serendipitously found to
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reduce neuropathic pain in patients.55,56 Since then, MCS has been proposed for the
treatment of other chronic neuropathic pain conditions including SCI pain,48–51,58 and
several noninvasive MCS protocols have been developed; these include transcranial
magnetic stimulation and transcranial direct current stimulation.23,28 Some authors report
that MCS results in pain relief in approximately 50% of the patients24; however, evidence
from placebo-controlled trials to support these claims is lacking.10 Pain relief occurs
progressively after the onset of MCS19 and persists after the stimulation has stopped. This
poststimulation effect can last from minutes to days in some patients21,22 and suggests that
MCS could potentially serve as a therapy for treatment-resistant neuropathic pain. However,
the mechanisms by which MCS alleviates pain remain poorly understood.
Recently, we described a novel system for the regulation of nociceptive processing in the
thalamus, the incertothalamic system.31 In this system, the zona incerta (ZI; a GABAergic
nucleus located in the diencephalon) inhibits the flow of nociceptive and somatosensory
information in the posterior thalamus (Po),31,54 and this inhibition is regulated by the
cholinergic system.32 In animals with SCI, we demonstrated that hypersensitivity is
associated with an abnormally reduced inhibition from ZI.31 The reduced inhibition results
in enhanced spontaneous and evoked activity in higher order thalamic nuclei (Po) and
cortical structures involved in nociceptive processing.31,43,45 In the same animals, we found
that MCS reverses spontaneous painlike behaviors and hypersensitivity without having an
effect on motor performance.11,27 We also found that electrical stimulation of ZI mimics
MCS effects and that reversible inactivation of ZI blocks antinociception produced by MCS,
suggesting an integral role for the ZI in mediating MCS effects.27 Because the main input to
ZI is from frontal cortical areas, and in particular the motor cortex (M1),33,34 and because ZI
projects densely upon Po,3,53 we hypothesized that antinociceptive effects of MCS are due
to the activation of the incertothalamic pathway.
Methods
General Surgical Procedures
All procedures were conducted according to Animal Welfare Act regulations and Public
Health Service guidelines. Strict aseptic surgical procedures were used, according to the
guidelines of the International Association for the Study of Pain, and approved by the
institutional Animal Care and Use Committee. Forty-eight adult male Sprague Dawley rats
weighing 250 to 300 g were used in this study. Animals were anesthetized with either
isoflurane (initial, 5%; during surgery, 1.5%) for SCI surgery or urethane (1.5 g/kg,
intraperitoneally) for in vivo electrophysiological recording experiments. The animals were
attached to a stereotaxic frame and placed on a thermoregulated heating pad. The respiratory
rate, corneal reflex, and tail pinch response were monitored and used to ensure that animals
were sufficiently anesthetized. Local anesthetic (2% lidocaine) was applied to incision sites
before surgery began.
SCI
A midline, longitudinal incision (10 mm) overlaying the C2-T2 area was made. The muscles
were dissected under a dissecting microscope with blunt scissors to expose vertebrae C6 and
C7. A laminectomy to expose the spinal cord immediately rostral to C7 was performed using
a rongeur, and the dura mater covering the spinal cord was removed. A quartz-insulated
platinum electrode (5-μm tip) was inserted into the anterolateral quadrant of the right side of
the spinal cord (2.1 mm lateral to the midline). DC current was passed (10 μA for 10
seconds repeated 5 times) at 2 locations to produce 2 lesions (lesion locations, .8 and 1.2
mm lateral from midline; depth, 1.7 mm) as described previously.11,27 After the end of SCI
surgery, the muscles and skin were approximated and sutured in layers. The animals were
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left to recover on a thermoregulated heated pad and the anti-inflammatory drug carprofen
(Rimadyl; Pfizer, Rouses Point, NY) 50 mg/mL, subcutaneously, was administered
postoperatively every 12 hours for 3 days.
Behavioral Testing
A Dynamic Plantar Aesthesiometer (Ugo Basile, Comerio, Italy) was used to assess bilateral
mechanical withdrawal thresholds on both hindpaws. To minimize anxiety, the animals were
acclimated to the behavioral apparatus 30 minutes before testing. The filaments were applied
on the plantar surface of the paws 3 times and mechanical withdrawal force was defined as
the average force at which the animal withdrew the paw. Withdrawal thresholds were
assessed on 3 consecutive days before SCI surgery, at day 3 postsurgery, at day 7
postsurgery, and at weekly intervals thereafter.
In Vivo Experiments
Extracellular Electrophysiological Recording—At least 14 days after surgery, rats
were anesthetized with urethane (1.5 g/kg, intraperitoneally) and prepared for extracellular
recordings as previously described.31 We selected urethane because it has no, or negligible,
effects on glutamatergic and GABAergic transmission and therefore produces only minimal
disruption of signal transmission in the neocortex.44 We monitored electrocorticograms to
assess the stage of anesthesia and maintained the rats at stage III/3– 416 and administered
supplementary injections (150 mg/kg) as needed.
We recorded from the ipsilateral ZI (stereotaxic coordinates: anteroposterior, 3.6; lateral,
2.9) and ipsilateral Po (anteroposterior, 3.4; lateral, 2.8), relative to the SCI site. The bone
overlying ZI or Po regions was removed and the dura covering the brain was carefully
dissected. Custom-made quartz-insulated platinum electrodes (2–4 MΩ) were used to record
from ZI or Po based on stereotaxic coordinates relative to Bregma. In Po, we recorded
spontaneous activity from neurons with receptive fields in the hindpaw as determined by
manual stimulation using a wooden probe. These neurons typically receive convergent
inputs from other parts of the body such as the vibrissa.31
MCS—The bone overlying the M1 was removed, and custom-made insulated bipolar
platinum electrodes (diameter, 70 μm; exposed tip, 50 μm; distance between electrodes, 500
μm) were applied epidurally above the M1 at stereotaxic coordinates determined from our
previous behavioral experiments (anterior, 1.8 mm; lateral, 2 mm)11,27 ipsilateral to the SCI
site. The MCS electrodes were held in place using 2 bone screws and acrylic resin and the
electrodes were connected to a stimulator (ISO-Flex and Master-8; A.M.P.I, Jerusalem,
Israel).
Experimental Protocol—We recorded spontaneous activity from well-isolated single
neurons in ZI and Po before (recorded for 5 minutes), during (recorded for either 5, 15, or 30
minutes), and after MCS until the cell recovered. In all experiments, we stimulated the M1
continuously at 50 μA, 50 Hz, 300-ms pulses because we have shown previously that these
parameters are effective in reducing hypersensitivity and spontaneous painlike
behaviors.11,27 However, we varied the duration of stimulation (5, 15, or 30 minutes) to
assess the effect of duration of stimulation on neuronal activity in ZI and Po. The waveforms
of signals recorded from well-isolated units were digitized (40 kHz) through a Plexon Data
Acquisition System (Plexon, Dallas, TX). The recorded units were sorted offline (Plexon’s
off-line sorter) using dual thresholds and principal component analyses.
Pharmacologic Inactivation of ZI—In a subset of animals (n = 5), a microdialysis
probe (CMA11; Microdialysis, Solna, Sweden) was implanted into ZI using stereotaxic
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coordinates38 Muscimol (200 μM, GABAA agonist; Sigma-Aldrich, St. Louis, MO) was
infused using a pump (Genie Plus; Kent Scientific, Kent, CT) at a rate of 2.5 μL/min into ZI
10 minutes before recording from neurons in Po because we found in previous experiments
that muscimol infusion requires at least 5 minutes to produce behavioral effects.27 Muscimol
infusion continued for the duration of the experiment, and spontaneous activity of Po
neurons was assessed before, during, and after 15 minutes of MCS.
Pyramidotomy—In a subset of animals (n = 5), the pyramidal tract was cut bilaterally at
the level of the medulla oblongata before recording from Po neurons to remove any
influence of MCS on ascending afferents in the spinal cord. In these animals, the bone
covering the medullary pyramids was removed and the dura was dissected. The pyramids
were cut 1.5 mm rostral to decussation with a #11 scalpel blade (Butler Schein, Albany, NY)
as described in Z’Graggen et al.62
Histology—At the end of recording experiments, electrolytic lesions (20 μA for 10
seconds repeated 2 times) were used to mark the recording sites. The animals were then
perfused transcardially with buffered saline followed by 4% buffered paraformaldehyde. We
obtained coronal brain and spinal sections (80 μm thick) and Nissl-stained each section. The
sections were examined under the microscope to identify recording sites, lesion sites, and
muscimol injection location in experiments where ZI was inactivated.
Data Analysis
Mechanical Hypersensitivity—To determine if mechanical thresholds were changed
significantly after spinal injury, analysis of variance (ANOVA) on ranks was performed
followed by Dunn’s multiple comparison test using the average of 3 presurgical baseline
trials and the average of each postsurgical trial at days 3, 7, and 14. All the animals included
in this study exhibited significant reductions in mechanical withdrawal thresholds. Changes
in mechanical withdrawal thresholds were used only as an assay to demonstrate that
hypersensitivity occurs after spinal cord injury. We demonstrated previously, in these
animals, that reduction in mechanical withdrawal thresholds is associated with the
development of a tonic aversive state suggesting the presence of ongoing spontaneous
painlike behavior.11
The Effect of MCS on Spontaneous Activity of Individual Neurons in ZI and Po
—For each cell, spontaneous activity before, during, and after MCS was divided into 1-
minute blocks. The mean firing rate during each minute (or block) was calculated, and
repeated measures ANOVA (RM ANOVA) followed by Dunn’s multiple comparison test
was used to test if mean firing rate in each block after MCS has changed significantly from
baseline values. Data obtained during electrical stimulation were not included in the
statistical analysis because we could not reliably eliminate the stimulus artifact. Neurons
with at least 2 consecutive significantly changed blocks (P < .05; in the same direction,
either enhanced or suppressed) were considered significantly changed and subsequently
classified into neurons with enhanced or suppressed spontaneous activity. Neurons that did
not meet these criteria were not affected by MCS.
The Magnitude and Duration of MCS Effects in ZI and Po—The mean firing rate
across significantly changed blocks, for each cell, was calculated before and after MCS
(separately for enhanced and suppressed units) and then averaged across neurons to assess
enhanced or suppressed spontaneous activity in neuronal populations. The Wilcoxon signed-
rank test was used to compare the averaged mean firing rate for neuronal populations before
and after MCS. In addition, Spearman rank order test was used to test for correlation
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between the change in mean firing rate in neuronal population after MCS and the duration of
MCS (5, 15, and 30 minutes).
The length of time that spontaneous activity was enhanced or suppressed after MCS
(duration of MCS effects) was also assessed by summing the duration of significantly
changed blocks for each unit after MCS. The duration of MCS effects was averaged across
neurons to assess the duration of MCS effects in ZI and Po neurons as a group. In some
units, we were unable to record from the neurons until they completely recovered, and
therefore these units were not included in our analysis of the duration of effects. Spearman
rank order test was used to test for correlation between the duration of enhanced or
suppressed spontaneous activity after MCS and duration of electrical stimulation (5, 15, and
30 minutes).
Histological Analysis—Nissl-stained slides were examined under the microscope to
identify recording tracts and electrolytic lesions in ZI and Po. Electrolytic lesions and
electrode tracts were cross-referenced with the stereotaxic coordinates of penetrations
recorded during the recording experiments. The approximate location of each neuron within
ZI or Po was determined and plotted on a drawing obtained from the Paxinos and Watson
Atlas.38 Postmortem histological analysis was performed blindly (blinded to the result of
MCS effect on individual neurons).
In all experiments, data were analyzed using Sigma-Stat program (Aspire Software
International, Ashburn, VA). A P < .05 was considered significant.
Results
We and others have previously shown that rats with SCI develop mechanical
hypersensitivity caudal to the lesion site.11,31,61 Consistent with the literature, animals in
this study showed a significant reduction in mechanical hindpaw withdrawal thresholds
bilaterally within 7 days of the injury. On the ipsilateral hindpaw (relative to the injury)
mechanical thresholds decreased from 35.2 ± 1.3 g (median, 35.5 g; range, 27.0–47.4 g) to
22.9 ± 3.7 g (median, 21.9 g; range, 17.1–36.4 g; P < .001, ANOVA on ranks). We observed
similar results on the contralateral hindpaw and mechanical withdrawal thresholds decreased
from 36.3 ± 1.3 g (median, 35.3 g; range, 31.2–48.8 g) to 25.6 ± 3.8 g (median, 25.3 g;
range, 18.1–33.1 g; P < .001).
Effects of MCS on ZI Activity
We recorded from 72 well-isolated single units in ZI and assessed spontaneous activity
before and immediately after continuous MCS (see Methods). Figs 1A–C shows
representative examples of ZI neurons exhibiting enhanced activity after 5, 15, or 30
minutes of MCS. In these examples, MCS enhanced spontaneous activity by 264% after 5
minutes of MCS (Fig 1A) and by 366% and 281% after 15 and 30 minutes stimulation,
respectively (Figs 1B and 1C). In individual neurons, MCS significantly enhanced
spontaneous activity in 35% of ZI units (25/72; P < .02, RM ANOVA). As a group,
spontaneous activity was enhanced on average by 220% (P = .0007, Wilcoxon) after 5
minutes of MCS, by 439% (P < .001) after 15 minutes of stimulation, and by 363% (P = .02)
after 30 minutes of stimulation (Figs 1D–F). As a group, there was no correlation between
the change in spontaneous activity and the duration of MCS (rho = .18, P = .39, Spearman;
Fig 1G). However, there was a significant positive correlation between the duration of
enhanced spontaneous activity after MCS and the duration of MCS (5-minute MCS: 10.3 ±
1.7 minutes; median, 11.5 minutes; range, 3.0–14.0 minutes; 15-minute MCS: 11.3 ± 1.5
minutes; median, 16.0 minutes; range, 2.0–18.0 minutes; 30-minute MCS: 20.2 ± 4.6
minutes; median, 25.0 minutes; range, 4.0–30.0 minutes; rho = .5, P = .01, Spearman; Fig
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1H). These results are consistent with our previous findings that MCS reduces spontaneous
painlike behaviors in animals with SCI and that the duration of stimulation correlates
positively with the duration of antinociception produced.11,27
However, not all ZI neurons were enhanced after MCS. In 26% (19/72) of ZI cells
spontaneous activity was significantly suppressed (P < .001, RM ANOVA), and in the
remaining neurons MCS had no effect on spontaneous activity (Table 1). The ZI contains a
heterogenous collection of cells and is compromised of several sectors33,42,46; therefore, the
mixed results we observe after MCS could be due to the heterogeneity of the sampled ZI
neurons. To test this notion, we performed a postmortem histological analysis to identify the
location of recorded ZI neurons. We divided the ZI into 4 sectors by drawing a horizontal
line bisecting ZI into ventral and dorsal portions and another vertical line in the middle of
ZI, perpendicular to the horizontal line. We found that the majority of neurons exhibiting
enhanced activity after MCS (81%, 13/16) were located in the ventrolateral portion of ZI
(Fig 2), an area shown previously to provide inhibitory inputs to Po.3,54 All other neurons
(suppressed or no change in activity after MCS) were distributed evenly in ZI. These
findings support our overarching hypothesis that antinociceptive effects of MCS are due to
enhanced ZI inputs to Po.
Effects of MCS on Po Activity
MCS suppressed spontaneous activity in the majority of Po neurons (58%, 32/55 cells; P < .
001, RM ANOVA). Only a small percentage (15%, 8/55) of Po neurons exhibited enhanced
spontaneous activity after MCS (P < .02), and in 27% (15/55 cells) MCS had no significant
effects (P > .05) (Table 2). In Figs 3A–C we show representative examples of the effects of
MCS on Po activity. MCS suppressed spontaneous activity by 19% after 5 minutes of MCS
(Fig 3A) and by 53% and 37% after 15 and 30 minutes stimulation, respectively (Figs 3B
and 3C). As a group, spontaneous activity was suppressed by 51% after 5 minutes of MCS
(range, 1.7–84.7%; P = .007, Wilcoxon), by 50% after 15 minutes of MCS (range, .3–74%;
P = .001), and by 25% after 30 minutes of MCS (range, 6.1–54%; P = .014) (Figs 3D–F).
There was no correlation between the change in spontaneous activity and the duration of
stimulation (rho = .28, P = .13, Spearman; Fig 3G). Similar to the effect of MCS on ZI, the
duration of suppressed activity in Po after MCS was positively correlated with the duration
of MCS (5-minute MCS: mean, 11.7 ± 2.2 minutes; median, 12.0 minutes; range, 3.0–26.0
minutes; 15-minute MCS: mean, 15.2 ± 2.3 minutes; median, 17.0 minutes; range, 3.0–30.0
minutes; 30-minute MCS: mean, 22 ± 3.6 minutes; median, 22.5 minutes; range, 13.0–30.0
minutes; rho = .4, P = .03, Spearman; Fig 3F). The locations of recorded Po units are shown
in Fig 4.
It has been suggested that MCS directly inhibits nociceptive neurons in the dorsal horn,1,25
and therefore suppressed activity in Po could be due to MCS inhibition of ascending
nociceptive inputs from the spinal cord rather than due to MCS-enhanced ZI activity. To
allay this concern, in a subset of animals (n = 5), we performed bilateral pyramidotomy at
the level of the caudal medulla and recorded Po responses to 15 minutes of MCS (see
Methods). Cutting the pyramidal tract did not block the effects of MCS, and spontaneous
activity of the majority of Po neurons (75%) was suppressed after stimulation. A
representative example is shown in Fig 5A where spontaneous activity was significantly
suppressed from a mean of 2.5 ± .2 spikes/second to .2 ± .0 spikes/second after 15 minutes
of MCS (P < .001, RM ANOVA). These findings suggest that MCS effects are not due to
direct influence of MCS on ascending spinal afferents.
To determine if the suppressed activity in Po is mediated through MCS activation of ZI, in a
subset of animals (n = 8), we pharmacologically inactivated ZI and assessed the effects of
MCS (15 minutes) on Po activity. In the representative example shown in Fig 5B, MCS had
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no effect on spontaneous activity of a Po neuron when muscimol was infused in ZI (11.7 ± .
8 spikes/second to 10.7 ± .4 spikes/second; P = .987, RM ANOVA). The infusion of
muscimol blocked the effects of MCS in the majority (73%) of Po neurons studied.
Although we cannot dismiss the possibility that muscimol diffused beyond the boundary of
ZI, these findings suggest that MCS suppresses activity in Po by activating ZI.
Discussion
Our overarching hypothesis is that MCS ameliorates pain by activating the incertothalamic
pathway. This hypothesis arises from our previous findings that reduced hypersensitivity
after MCS can be mimicked by electrical stimulation of ZI and that antinociception is
blocked by inactivating ZI.27,30 In agreement with this hypothesis, we demonstrate that
MCS enhances spontaneous activity in putative Po-projecting ZI neurons and suppresses
activity in the majority of Po neurons. We also demonstrate that suppressed activity in Po
remains even when the pyramidal tract is cut. The effects of MCS on ZI and Po activity
outlasted the stimulation period and were dependent on the duration of stimulation. These
findings are in agreement with previous reports in animals and humans that the behavioral
effects of MCS outlast the stimulation period and are dependent on the duration of
stimulation.22,27
Enhanced Activity in ZI
GABAergic, Po-projecting neurons are located in the ventrolateral portion of ZI (see Fig 1
in Trageser et al54) and M1 fibers innervating ZI terminate densely in the ventral portion
(ZIv).34,57 Despite their proximity within ZIv, Po-projecting ZI neurons are not directly
influenced by M1 inputs.57 Because ZIv neurons are GA-BAergic and because they have
extensive local axon collaterals, it was suggested that excitatory input from M1 may result in
increased intranuclear inhibition and therefore suppress rather than enhance activity in Po-
projecting ZI neurons.57 However, we find that neurons in the lateral portion of ZIv
(putative Po-projecting ZI neurons) are enhanced after MCS. A possible explanation is that
continuous MCS of ZIv neurons that receive direct input from M1 depletes GABA. This will
result in disinhibition of Po-projecting ZI neurons and enhanced inhibitory inputs from ZI to
Po. Consistent with this notion, we find that longer MCS periods result in prolonged
enhanced activity in ZI and suppressed activity in Po.
Furthermore, it is possible that inhibitory inputs other than those from ZI are enhanced by
MCS. An important source of inhibitory inputs to the thalamus is the GABAergic reticular
nucleus (TRN). Unlike ZI, the major source of excitatory input to TRN is from the
somatosensory cortex.26 Further, GABAergic terminals in Po that originate from ZI differ
from those of TRN by their larger size, the presence of multiple release sites, and multiple
filamentous contacts, all features suggesting that ZI exerts significantly more potent
inhibition upon Po.3,4 Another source of GABAergic input to Po that may be influenced by
MCS is the anterior pretectal nucleus.4,35 The anterior pretectal nucleus is implicated in
regulating nociceptive responses.59,60 It receives direct inputs from M15 and is a target that
we will explore in the future.
Suppressed Activity in Po
In addition to ZI, M1 projects directly to Po and MCS may result in enhanced activity in Po
rather than suppression. However, only a small percentage of Po neurons (3.9%) are
activated directly by electrical stimulation of M1,47 which suggests that the suppressed
activity of Po neurons observed in our study is due to the indirect effects of MCS on ZI. In
agreement with this, we found that the infusion of muscimol into ZI blocked the effects of
MCS on the majority of, but not all, Po neurons. The partial effects of muscimol are possibly
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due to incomplete block of ZI. At the same time, it is possible that muscimol may have
diffused beyond the boundaries of ZI and affected neighboring structures such as the internal
capsule or the ventroposterior thalamus; therefore, results from inactivation experiments
should be interpreted with caution.
Specificity of MCS Effects
We focused our efforts on studying the ZI and PO because they have been shown to play a
major role in the pathogenesis and the development of SCI pain, especially when compared
to other brain structures involved in nociceptive processing such as the ventroposterior
thalamus.31 Nonetheless, it is important to note that M1 projections are diffuse and target
numerous cortical and subcortical structures, and therefore antinociceptive effects of MCS
may not only be due to the activation of the incertothalamic pathway. MCS effects could be
due to influences on other brain structures such as the ventroposterior thalamus, primary
somatosensory cortex, and periaqueductal gray. Additional studies are needed to test the
effect of MCS on activity in these structures. Similarly, in addition to Po, ZI innervates the
mediodorsal thalamus, nucleus submedius, and other higher order thalamic nuclei involved
in nociceptive processing. Activity in these nuclei may also be suppressed by MCS.
Mechanisms of Pain Relief After MCS
Several hypotheses have been proposed to explain how MCS causes pain relief. Some
authors hypothesized that MCS reduces pain by suppressing nociceptive inputs in the spinal
cord either directly1,25 or indirectly by activating the descending inhibitory
systems.15,29,36,37 However, manipulations that activate endogenous opioid release, such as
deep brain stimulation of the periaqueductal gray, are especially poor for the treatment of
pain resulting from an injury to the central nervous system.20,52 In addition, we found that
suppressed activity in Po remains even when the M1 inputs to the spinal cord were
eliminated, suggesting that suppressed activity is not due to direct inhibition of ascending
spinal afferents but is likely due to effects of MCS on supraspinal structures.
Evidence from imaging studies further supports a supraspinal mechanism of pain relief after
MCS. It has been shown that MCS increases regional cerebral blood flow in several regions
including the thalamus, striatum, and anterior cingulate cortex.17,18,39–41 Some authors have
hypothesized that MCS activates corticothalamic connections, and these in turn inhibit
nociceptive processing in the thalamus.6,7 In support of this hypothesis, it was argued that
patients responsive to GABA or barbiturate treatment are more likely to benefit from
MCS.8,9 However, the specific role of the thalamus is still debatable,19,39 and the source of
altered inhibition, the mechanisms for engagement of inhibition, and the specific nuclei
affected by MCS remain to be elucidated.
Here, we describe a novel inhibitory brain circuit that can be manipulated to produce pain
relief. At the center of this circuit is the ZI that potently regulates the flow of nociceptive
information from the posterior thalamus to the cortex. We have demonstrated previously that
activating or inhibiting this circuit is causally related to the development of hypersensitivity
and spontaneous pain-like behavior in animals after SCI.11 Along with our present findings,
these results support the conclusion that MCS ameliorates pain by activating the
incertothalamic pathway. Increased inhibition within the thalamus will hinder the flow of
nociceptive information to cortical areas involved in nociceptive processing such as the
somatosensory cortex, the anterior cingulate cortex, and the insula, and will result in reduced
pain.
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Figure 1.
MCS effects on spontaneous activity in ZI. (A–C) Representative examples of ZI response
to 5 (A), 15 (B), and 30 (C) minutes of MCS (solid horizontal bar). Change in mean firing
rate for each cell was calculated and plotted during 1-minute blocks. Statistical analysis was
performed using RM ANOVA. Insets represent waveforms of recorded units sorted using a
spike matching algorithm (Plexon, Offline Sorter). (D–F) Box plots of the mean firing rate
of ZI neurons exhibiting enhanced spontaneous activity before and after 5 (D), 15 (E), 30
(F) minutes of MCS. The solid horizontal line in the box plots represents the median value
and the dashed horizontal line represents the mean value. In this figure and the following
figures, the box plots represent the 25th and 75th percentile and the error bars represent the
10th and 90th percentile. Statistical analysis was performed using Wilcoxon signed-rank
test. (G) The correlation between the change in mean firing rate for ZI neurons exhibiting
enhanced activity after MCS and the duration of stimulation. (H) The correlation between
the duration of enhanced activity in ZI neurons after MCS and the duration of stimulation.
Cha et al. Page 12
J Pain. Author manuscript; available in PMC 2013 March 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Correlation analysis was performed using the Spearman’s Rho test. P < .05 was considered
significant.
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Figure 2.
Postmortem analysis of ZI recording sites. (A) Locations of recorded ZI neurons were
determined and identified on corresponding drawings obtained from the Paxinos and Watson
Atlas.38 The ZI was divided into 4 sectors by drawing a horizontal line bisecting ZI into
ventral and dorsal portions and another vertical line in the middle of ZI, perpendicular to the
horizontal line (●, enhanced cell; ○, suppressed cell; Δ, no significant change). (B) The
number of enhanced ZI units within each sector of ZI. Abbreviations: VPM,
ventroposteromedial nucleus; VPL, ventroposterolateral nucleus; VM, ventromedial
nucleus; IC, internal capsule.
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Figure 3.
MCS effects on spontaneous activity in Po. (A–C) Representative examples of Po response
to 5 (A), 15 (B), and 30 (C) minutes of MCS (solid horizontal bar). Change in mean firing
rate for each cell was calculated and plotted during 1-minute blocks. Statistical analysis was
performed using RM ANOVA. Insets represent waveforms of recorded units sorted using a
spike matching algorithm. (D–F) Box plots of the mean firing rate of Po neurons exhibiting
suppressed spontaneous activity before and after 5 (D), 15 (E), and 30 (F) minutes of MCS.
Statistical analysis was performed using Wilcoxon signed-rank test. (G) The correlation
between the change in mean firing rate for Po neurons exhibiting suppressed activity after
MCS and the duration of stimulation. (H) The correlation between the duration of
suppressed activity in Po neurons after MCS and the duration of stimulation. Correlation
analysis was performed using the Spearman’s Rho test. P < .05 was considered significant.
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Figure 4.
Postmortem analysis of Po recording sites. Locations of recorded Po neurons were
determined and identified on corresponding drawings obtained from the Paxinos and Watson
Atlas38 (●, enhanced cell; ○, suppressed cell; △, no significant change). Abbreviation:
LDVL, laterodorsal thalamic nucleus, ventrolateral part.
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Figure 5.
Suppressed activity in Po is due to MCS effects on ZI. (A) A representative example of a Po
unit exhibiting suppressed activity after 15 minutes of MCS (horizontal solid line) when the
pyramidal tract was cut. (B) A representative example of a Po unit exhibiting no change in
activity after 15 minutes of MCS (horizontal solid line) when the ZI was inactivated using
continuous infusion of muscimol (200 μM, GABAA agonist; 2.5 μL/min). Insets represent
waveforms of recorded units sorted using a spike-matching algorithm.
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Table 1
The Effect of MCS on Spontaneous Activity of ZI
Duration of MCS Enhanced Suppressed No Change
5 minutes 42% (6/14) 14% (2/14) 42% (6/14)
15 minutes 31% (14/45) 35% (16/45) 34% (15/45)
30 minutes 38% (5/13) 7% (1/13) 65% (7/13)
Total 35% (25/72) 26% (19/72) 39% (28/72)
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Table 2
The Effect of MCS on Spontaneous Activity in Po
Duration of MCS Enhanced Suppressed No Change
5 minutes 17% (3/18) 61% (11/18) 22% (4/18)
15 minutes 11% (3/27) 56% (15/27) 33% (9/27)
30 minutes 20% (2/10) 60% (6/10) 20% (2/10)
Total 15% (8/55) 58% (32/55) 27% (15/55)
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